Dr Reddy’s Laboratories (RDY) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Dr. Reddy’s Laboratories has approved the grant of stock options to eligible employees under its 2018 Employee Stock Option Scheme, with 4,820 options available at an exercise price of Rs. 1,274 per share. This move is part of the company’s efforts to incentivize and retain talent, aligning employees’ interests with those of shareholders. The options are set to vest equally over four years.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.